Staying on track with anti-rejection medicines after kidney transplant
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study tests ways to help kidney transplant patients take their anti-rejection medicines exactly as prescribed. It may help you keep your new kidney healthy and avoid complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a kidney transplant at least one month ago.
- You are able to understand and agree to take part in the study.
- You can communicate by phone.
- You are willing to attend follow-up sessions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a special type of immune cell (Treg cells) to standard therapy can help kidney transplant recipients safely take lower doses of anti-rejection medicines. It is for people who are getting a kidney from a living donor.
This trial tests whether a short instructional video helps patients manage their medications correctly after a kidney transplant and during follow-up visits. It may improve how well patients stick to their medication plan.
This study looks at how to better manage anti-rejection medicines (tacrolimus and mycophenolate) in children and teens who have had an organ transplant. It uses text messages to help monitor drug levels, which might make treatment easier and safer.
This study tests whether continuing certain anti-rejection medicines while on dialysis can help lower the risk of your immune system becoming too sensitive to a future kidney transplant. It might help you stay eligible for another transplant later.
This study tests a program to help organ transplant patients remember to take their anti-rejection medicines correctly. It aims to improve medication adherence and overall health after transplantation.
This study tests whether a special blood test can help monitor your new kidney after transplant. It may help doctors spot problems earlier and improve kidney health.
Hear when a new Kidney Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.